Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.14M Sell
25,979
-83
-0.3% -$29.6K 2.47% 17
2025
Q4
$8.53M Buy
26,062
+380
+1% +$121K 2.4% 17
2025
Q3
$7.66M Buy
25,682
+875
+4% +$254K 2.23% 18
2025
Q2
$6.93M Buy
24,807
+1,017
+4% +$288K 2.37% 16
2025
Q1
$7.41M Sell
23,790
-15
-0.1% -$4.43K 2.82% 13
2024
Q4
$6.2M Buy
23,805
+783
+3% +$232K 2.5% 16
2024
Q3
$7.42M Buy
23,022
+85
+0.4% +$27.8K 3.18% 13
2024
Q2
$7.17M Sell
22,937
-352
-2% -$103K 3.27% 11
2024
Q1
$6.62M Buy
23,289
+592
+3% +$173K 3.03% 15
2023
Q4
$6.54M Buy
22,697
+289
+1% +$78.7K 3.35% 13
2023
Q3
$6.02M Buy
22,408
+1,581
+8% +$395K 3.39% 10
2023
Q2
$4.62M Buy
20,827
+341
+2% +$79.1K 2.58% 18
2023
Q1
$4.95M Buy
20,486
+24
+0.1% +$5.89K 2.83% 16
2022
Q4
$5.37M Buy
20,462
+344
+2% +$92.2K 3.17% 11
2022
Q3
$4.54M Buy
20,118
+179
+0.9% +$43.4K 2.96% 12
2022
Q2
$4.85M Buy
19,939
+577
+3% +$141K 2.99% 12
2022
Q1
$4.68M Buy
19,362
+1,248
+7% +$287K 2.46% 20
2021
Q4
$4.08M Buy
18,114
+2,594
+17% +$547K 2.07% 23
2021
Q3
$3.3M Buy
15,520
+1,594
+11% +$367K 1.96% 24
2021
Q2
$3.39M Buy
13,926
+750
+6% +$185K 2.04% 24
2021
Q1
$3.28M Buy
13,176
+664
+5% +$158K 2.13% 24
2020
Q4
$2.88M Buy
12,512
+1,153
+10% +$266K 2.07% 24
2020
Q3
$2.89M Sell
11,359
-47
-0.4% -$11.6K 2.51% 15
2020
Q2
$2.69M Buy
11,406
+254
+2% +$58K 2.58% 15
2020
Q1
$2.26M Sell
11,152
-434
-4% -$94.8K 2.7% 15
2019
Q4
$2.79M Buy
+11,586
New +$2.55M 2.52% 20

Other funds holding AMGN

Fusion Capital's AMGN Position: Q1 2026 in Review

Fusion Capital reduced its Amgen (AMGN) stake by 0.32% in Q1 2026, selling an estimated $29.6K and leaving 25,979 shares worth $9.14M. The position accounts for 2.47% of the portfolio, ranked #17.

Fusion Capital first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fusion Capital held 25,979 shares of Amgen worth $9.14M as of Q1 2026.
  • Fusion Capital sold 83 Amgen shares in Q1 2026, an estimated $29.6K.
  • Amgen made up 2.47% of Fusion Capital's portfolio in Q1 2026, its #17 holding.
  • Fusion Capital first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fusion Capital's 13F filing for Q1 2026, filed 13 May 2026.